• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD EUFLEXXA 1% SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD EUFLEXXA 1% SODIUM HYALURONATE Back to Search Results
Catalog Number 6301182010
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Dyspnea (1816); Headache (1880); Hypersensitivity/Allergic reaction (1907); Memory Loss/Impairment (1958); Rash (2033); Arthralgia (2355); Joint Swelling (2356); Reaction, Injection Site (2442); Abdominal Cramps (2543); Lethargy (2560); Alteration In Body Temperature (2682)
Event Date 10/01/2016
Event Type  Injury  
Manufacturer Narrative
Not returned to manufacturer.
 
Event Description
Anaphylactic reaction [anaphylactic reaction], stomach cramps [abdominal pain upper], fever [pyrexia], rash [rash], lethargy [lethargy], flu like symptoms [influenza like illness], neck pain [neck pain], memory problems [memory impairment], knees hurt worse [arthralgia], had trouble breathing [dyspnoea], swelling in all joints [joint swelling], headache [headache], did not work [device ineffective]. This serious regulatory authority, complaint, spontaneous report was received from a non health professional in united states. This report concerns a patient of unknown age and gender who experienced anaphylactic reaction, stomach cramps, fever, rash, lethargy, flu like symptoms, neck pain, memory problems, knees hurt worse, had trouble breathing, swelling in all joints, headache, and did not work during treatment with intra-articular euflexxa (sodium hyaluronate) solution for injection unknown concentration, for arthralgia from 2016 to 2016. The patient reported that after the first injection of euflexxa they experienced severe stomach cramps. After the second injection (date not provided) they experienced anaphylactic reaction, fever, rash, severe lethargy, headache, and swelling in all joints. They also reported flu like symptoms, neck pain, memory problems, knees hurt worse, and had trouble breathing. The patient reported that euflexxa did not work and refused third set of injections. The anaphylactic reaction was medically significant. Action taken with euflexxa was dose withdrawn. At the time of this report, the outcome of all of the events was unknown. The patient`s past drug therapy was significant for synvisc (from unknown start date to unknown stop date). Concomitant medication use was not reported. At the time of reporting the case outcome was unknown. Ferring global pharmacovigilance added the narrative since no narrative was provided. Overall listedness (core label) is unlisted. Reporter causality: related. Company causality: unassessable. Other case numbers: case number, others
=
mw5065512. This ae occurred in the us and concerns the medical device euflexxa. Please report to your local health authority if required by local law. This ae is not reportable in eu because it does not meet the definition of a medical device incident according to the requirements of the medical device directive, because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer. No corrective action was performed by the manufacturer or requested by regulators. Argus number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameEUFLEXXA
Type of Device1% SODIUM HYALURONATE
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD
be'er tuvia industrial zone
kiryat malachi, 83104
IS 83104
Manufacturer (Section G)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD
be'er tuvia industrial zone
kiryat malachi, 83104
IS 83104
Manufacturer Contact
100 interpace parkway
parsippany, NJ 07054
9737961600
MDR Report Key6136266
MDR Text Key61158832
Report Number3000164186-2016-00039
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
PMA/PMN Number
P010029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation
Type of Report Initial
Report Date 11/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/30/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue Number6301182010
Was Device Available for Evaluation? No
Is the Reporter a Health Professional?
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received11/15/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 11/30/2016 Patient Sequence Number: 1
-
-